MODIFICATION TO BLUE SKY DENTAL IMPLANT SYSTEM
Device Facts
| Record ID | K021833 |
|---|---|
| Device Name | MODIFICATION TO BLUE SKY DENTAL IMPLANT SYSTEM |
| Applicant | Blue Sky Bio |
| Product Code | DZE · Dental |
| Decision Date | Jun 10, 2002 |
| Decision | SESE |
| Submission Type | Special |
| Regulation | 21 CFR 872.3640 |
| Device Class | Class 2 |
| Attributes | Therapeutic |
Indications for Use
The Blue Sky Bio Dental Implant System is intended for use in either partially or fully edentulous mandibles and maxillae to give support to single or multiple units fixed dental prosthesis. It is also intended to give support to overdentures by means of o-ring abutments or bar-attachments.
Device Story
Blue Sky Bio Dental Implant System consists of root form dental implants and associated abutment systems; used for prosthetic restoration in edentulous or partially edentulous patients. Implants are surgically placed in maxilla or mandible by clinicians; supports single/multiple unit fixed prostheses or overdentures via o-ring/bar attachments. System supports one-stage or two-stage surgical protocols; not intended for immediate loading. Clinicians use device to restore oral function and aesthetics for patients requiring tooth replacement.
Clinical Evidence
No clinical data provided; bench testing only.
Technological Characteristics
Root form dental implants and abutment systems. Supplied sterile or non-sterile. Supports one-stage and two-stage surgical protocols. Materials and specific standards not detailed in provided text.
Indications for Use
Indicated for implantation into fully or partially edentulous maxilla and mandible to support single or multiple unit fixed or removable dental prostheses.
Regulatory Classification
Identification
An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.
Special Controls
*Classification.* (1) Class II (special controls). The device is classified as class II if it is a root-form endosseous dental implant. The root-form endosseous dental implant is characterized by four geometrically distinct types: Basket, screw, solid cylinder, and hollow cylinder. The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)(2) *Classification.* Class II (special controls). The device is classified as class II if it is a blade-form endosseous dental implant. The special controls for this device are:(i) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use; (ii) Mechanical performance (fatigue) testing under simulated physiological conditions to demonstrate maximum load (endurance limit) when the device is subjected to compressive and shear loads; (iii) Corrosion testing under simulated physiological conditions to demonstrate corrosion potential of each metal or alloy, couple potential for an assembled dissimilar metal implant system, and corrosion rate for an assembled dissimilar metal implant system; (iv) The device must be demonstrated to be biocompatible; (v) Sterility testing must demonstrate the sterility of the device; (vi) Performance testing to evaluate the compatibility of the device in a magnetic resonance (MR) environment; (vii) Labeling must include a clear description of the technological features, how the device should be used in patients, detailed surgical protocol and restoration procedures, relevant precautions and warnings based on the clinical use of the device, and qualifications and training requirements for device users including technicians and clinicians; (viii) Patient labeling must contain a description of how the device works, how the device is placed, how the patient needs to care for the implant, possible adverse events and how to report any complications; and (ix) Documented clinical experience must demonstrate safe and effective use and capture any adverse events observed during clinical use.